Intramuscular Transplantation of Allogeneic Mesenchymal Stromal Cells Derived from Equine Umbilical Cord

Abstract

Background and ObjectivesMesenchymal stromal cells (MSCs) have great therapeutic potential, particularly in the process of tissue repair and immunomodulation through the secretion of biomolecules. Thus, the aim of this study was to evaluate the hypothesis that intramuscular transplantation of allogeneic MSCs obtained from equine umbilical cord (UC-MSCs) is safe, demonstrating that this is a suitable source of stem cells for therapeutic use.Methods and ResultsFor this, UC-MSCs were cultured, characterized and cryopreserved for future transplantation in six healthy mares. On day 0, transplantation of three million UC-MSCs diluted in Hank’s Balanced Solution (HBSS) was performed on right and left sides of the rump muscle. As a control, HBSS injections were performed caudally in the same muscle. Muscle biopsies were obtained as a control 30 days before transplantation (D-30). The biopsies were collected again on day 2 (left side) and day 7 (right side) post transplantation and examined histologically. All procedures were preceded by ultrasound examination and blood sampling. Hematologic evaluation remained within normal limits and no differences were observed between time points (p>0.05). Ultrasound examination was suggestive of inflammation 48 hours after transplantation in both groups (control and treated). At histological evaluation it was found only discrete inflammation signals between D-30×D2 (p<0.05) in the treated group, without differences (p> 0.05) between the groups at different time points.ConclusionsEquine UC-MSCs under the experimental conditions did not promote severe inflammation that causes tissue damage or lead to its rejection by the host organism and therefore has a good potential for clinical use.

The Potential of Mesenchymal Stem Cells to Treat Systemic Inflammation in Horses

“…Umbilical cord derived MSCs injected intramuscularly did not cause a significant inflammatory response. There was no difference in the muscle histopathology between MSC injections and controls (130).…”

Allogeneic mesenchymal stem cell transplantation in healthy equine superficial digital flexor tendon: A study of the local inflammatory response

“…In the histopathological analysis, the presence of an inflammatory reaction was verified through the degree of tissue organization and the presence and qualifying of the inflammatory infiltrate according to cell type, following the parameters described by Nixon et al (2008). The intensity of the inflammatory infiltrate was evaluated according to Dias et al (2016). Briefly, the assessment can be summarized as follows: a score of 0 or absent: the absence of inflammatory infiltrate; a score of 1 or barely discernible: 1 to 10 mononuclear inflammatory cells in a high power field (400x), showing a focal distribution; a score of 2 or mild: 11 to 20 mononuclear inflammatory infiltrates in a high power field (400×), with a multifocal distribution; and a score of 3 or intense: > 20 mononuclear inflammatory cells in a high power field (400x), with a diffuse distribution.…”

Clinical safety of intratesticular transplantation of allogeneic bone marrow multipotent stromal cells in stallions

“…The concentration, volume and procedure of MSCs injection used in the present experiment were based on previous studies performed by our group (Dias et al, ). The total volume was divided into several points of injection to avoid tissue distention and physical damage to the parenchymal tissue.…”